carbostyril has been researched along with Bronchiectasis in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Mulrennan, S; Popowicz, N; Vekaria, S; White, SW | 1 |
| Baqir, M; Colbenson, GA; Khawaja, A; Wylam, ME | 1 |
| Goss, CH; Jain, M | 1 |
| Hayes, D; Long, FR; McCoy, KS; Sheikh, SI | 1 |
| Falagas, ME; Trigkidis, KK; Vardakas, KZ | 1 |
| Asakura, K; Eguchi, K; Hasegawa, N; Horinouchi, H; Ishizaka, A; Izumi, Y; Kawamura, M; Kobayashi, K; Watanabe, M | 1 |
1 review(s) available for carbostyril and Bronchiectasis
| Article | Year |
|---|---|
Inhaled antibiotics beyond aminoglycosides, polymyxins and aztreonam: A systematic review.
Topics: Administration, Inhalation; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Bronchiectasis; Cystic Fibrosis; Fosfomycin; Humans; Pneumonia, Ventilator-Associated; Quinolones; Respiratory Tract Infections; Treatment Outcome | 2015 |
5 other study(ies) available for carbostyril and Bronchiectasis
| Article | Year |
|---|---|
To be or not to be on CFTR modulators during pregnancy: Risks to be considered.
Topics: Adult; Aminophenols; Bronchiectasis; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Delivery, Obstetric; Drug Dosage Calculations; Exocrine Pancreatic Insufficiency; Female; Gestational Age; Humans; Infant, Newborn; Lung Diseases; Monitoring, Physiologic; Mutation; Pregnancy; Pregnancy Complications; Pregnancy Outcome; Pseudomonas; Quinolones | 2020 |
A 48-Year-Old Woman With Chronic Cough, Dyspnea, and Bronchiectasis.
Topics: Alveolitis, Extrinsic Allergic; Aminophenols; Anti-Bacterial Agents; Bronchiectasis; Bronchoscopy; Cefazolin; Chloride Channel Agonists; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diagnosis, Differential; Female; Genetic Testing; Humans; Late Onset Disorders; Middle Aged; Quinolones; Staphylococcal Infections; Staphylococcus aureus; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Update in cystic fibrosis 2013.
Topics: Aminophenols; Bronchiectasis; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Evidence-Based Medicine; Humans; Life Expectancy; Mutation; Oxidative Stress; Prevalence; Quinolones; Risk Assessment; Risk Factors; Smoking | 2014 |
Improvement in bronchiectasis on CT imaging in a pediatric patient with cystic fibrosis on ivacaftor therapy.
Topics: Aminophenols; Bronchiectasis; Child; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Drug Monitoring; Female; Humans; Membrane Transport Modulators; Quinolones; Spirometry; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Early pulmonary resection for Mycobacterium avium complex lung disease treated with macrolides and quinolones.
Topics: Adult; Aged; Anti-Bacterial Agents; Antitubercular Agents; Bronchiectasis; Case Management; Clarithromycin; Combined Modality Therapy; Drug Resistance, Multiple, Bacterial; Female; Follow-Up Studies; Humans; Macrolides; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pneumonectomy; Quinolones; Sputum; Thoracoplasty; Time Factors; Treatment Outcome | 2006 |